• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在鉴别脑转移瘤放射性坏死进展方面,液体抑制酰胺质子转移加权成像优于渗漏校正动态磁敏感对比灌注成像。

Fluid-Suppressed Amide Proton Transfer-Weighted Imaging Outperforms Leakage-Corrected Dynamic Susceptibility Contrast Perfusion in Distinguishing Progression from Radionecrosis in Brain Metastases.

作者信息

Nichelli Lucia, Casagranda Stefano, Dipasquale Ottavia, Bensemain Mehdi, Papageorgakis Christos, Zucchelli Mauro, Jacob Julian, Valery Charles, Mathon Bertrand, Liebig Patrick, Zaiss Moritz, Lehéricy Stéphane

机构信息

Paris Brain Institute (PBI)-Institut du Cerveau (ICM), Sorbonne University, Inserm UMR S 1127, CNRS 7225, F-75013 Paris, France.

Department of Neuroradiology, La Pitié Salpêtrière Hospital, AP-HP Sorbonne University, F-75013 Paris, France.

出版信息

Cancers (Basel). 2025 Mar 31;17(7):1175. doi: 10.3390/cancers17071175.

DOI:10.3390/cancers17071175
PMID:40227736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11987914/
Abstract

Differentiating brain radionecrosis (RN) from tumor progression (TP) is a persistent clinical difficulty. Here, we compared the diagnostic accuracy of leakage-corrected relative cerebral blood volume (rCBV) and fluid-suppressed amide proton transfer-weighted (APTw) imaging in distinguishing between RN and TP in metastases. Subjects with enlarging lesions after stereotactic radiosurgery were prospectively examined at 3T. APTw data were acquired with a 3D snapshot-gradient echo sequence. B0 and B1 inhomogeneities were corrected using the WASAB1 protocol. rCBV was calculated according to established guidelines. Image analysis was performed using Olea Sphere 3.0 software. ΔAPTw and ΔrCBV were calculated as the average signal within the lesion normalized against the average signal in the contralateral white matter. A diagnosis of TP or RN was assessed by histology or imaging at follow-up. Independent samples -tests of ΔAPTw and ΔrCBV and the areas under the curve (AUCs) were computed. Twenty-one metastases (10 RN, 11 TP) were evaluated. APTw differentiated between RN and TP (U = 120, < 0.001), in contrast to rCBV (U = 71, = 0.174). The AUC was 0.991 (95% CI = 0.962-1.020) for ΔAPTw, and 0.636 (95% CI = 0.352-0.921) for ΔrCBV. The optimal cutoff points were 0.4 and 2.1 for ΔAPTw and ΔrCBV, respectively. The sensitivity and specificity for RN-TP were 100% and 90% for ΔAPTw and 63.6% and 36.4% for ΔrCBV. Fluid-suppressed APTw metrics enabled more accurate diagnostic performances than leakage-corrected rCBV metrics in distinguishing between RN and TP. These promising results suggest that APTw imaging could valuably complement current multiparametric MRI protocols in brain metastases follow-ups.

摘要

鉴别脑放射性坏死(RN)与肿瘤进展(TP)一直是临床难题。在此,我们比较了渗漏校正相对脑血容量(rCBV)和液体抑制酰胺质子转移加权(APTw)成像在鉴别转移性肿瘤中RN和TP的诊断准确性。对立体定向放射外科治疗后病灶增大的患者在3T条件下进行前瞻性检查。采用3D快照梯度回波序列采集APTw数据。使用WASAB1协议校正B0和B1不均匀性。根据既定指南计算rCBV。使用Olea Sphere 3.0软件进行图像分析。将ΔAPTw和ΔrCBV计算为病灶内平均信号相对于对侧白质平均信号的归一化值。通过随访时的组织学或影像学评估TP或RN的诊断。计算ΔAPTw和ΔrCBV的独立样本检验以及曲线下面积(AUC)。评估了21个转移瘤(10个RN,11个TP)。与rCBV(U = 71,P = 0.174)相比,APTw能够区分RN和TP(U = 120,P < 0.001)。ΔAPTw的AUC为0.991(95%CI = 0.962 - 1.020),ΔrCBV的AUC为0.636(95%CI = 0.352 - 0.921)。ΔAPTw和ΔrCBV的最佳截断点分别为0.4和2.1。对于RN - TP,ΔAPTw的敏感性和特异性分别为100%和90%,ΔrCBV的敏感性和特异性分别为63.6%和36.4%。在鉴别RN和TP方面,液体抑制APTw指标比渗漏校正rCBV指标具有更准确的诊断性能。这些有前景的结果表明,APTw成像在脑转移瘤随访中可有效补充当前的多参数MRI方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329d/11987914/e307860e10c5/cancers-17-01175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329d/11987914/f6f71a4ccde6/cancers-17-01175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329d/11987914/faf63be2c7d4/cancers-17-01175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329d/11987914/e307860e10c5/cancers-17-01175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329d/11987914/f6f71a4ccde6/cancers-17-01175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329d/11987914/faf63be2c7d4/cancers-17-01175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329d/11987914/e307860e10c5/cancers-17-01175-g003.jpg

相似文献

1
Fluid-Suppressed Amide Proton Transfer-Weighted Imaging Outperforms Leakage-Corrected Dynamic Susceptibility Contrast Perfusion in Distinguishing Progression from Radionecrosis in Brain Metastases.在鉴别脑转移瘤放射性坏死进展方面,液体抑制酰胺质子转移加权成像优于渗漏校正动态磁敏感对比灌注成像。
Cancers (Basel). 2025 Mar 31;17(7):1175. doi: 10.3390/cancers17071175.
2
Is pulsed saturation transfer sufficient for differentiating radiation necrosis from tumor progression in brain metastases?脉冲饱和转移技术足以区分脑转移瘤中的放射性坏死与肿瘤进展吗?
Neurooncol Adv. 2024 Jul 29;6(1):vdae132. doi: 10.1093/noajnl/vdae132. eCollection 2024 Jan-Dec.
3
The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T.3T下APTw CEST MRI在人脑肿瘤患者常规临床评估中的价值
Diagnostics (Basel). 2022 Feb 14;12(2):490. doi: 10.3390/diagnostics12020490.
4
Amide proton transfer-weighted imaging and derived radiomics in the classification of adult-type diffuse gliomas.酰胺质子转移加权成像及其衍生的放射组学在成人弥漫性胶质瘤分类中的应用。
Eur Radiol. 2024 May;34(5):2986-2996. doi: 10.1007/s00330-023-10343-6. Epub 2023 Oct 19.
5
Amide Proton Transfer-weighted (APTw) Imaging and Derived Quantitative Metrics in Evaluating Gliomas: Improved Performance Compared to Magnetization Transfer Ratio Asymmetry (MTR).酰胺质子转移加权(APTw)成像及衍生定量指标在评估胶质瘤中的应用:与磁化传递率不对称性(MTR)相比性能提升
Acad Radiol. 2025 May;32(5):2919-2930. doi: 10.1016/j.acra.2024.12.054. Epub 2025 Jan 13.
6
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.F-DOPA PET 和灌注 MRI 鉴别放疗后放射性坏死与进展性脑转移瘤的准确性。
Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):103-11. doi: 10.1007/s00259-014-2886-4. Epub 2014 Aug 15.
7
Amide proton transfer-weighted MRI in the clinical setting - correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T.3T场强下酰胺质子转移加权磁共振成像在临床中的应用——与成人胶质瘤患者治疗后成像中的动态对比增强磁共振灌注成像的相关性
Radiography (Lond). 2022 Feb;28(1):95-101. doi: 10.1016/j.radi.2021.08.006. Epub 2021 Sep 8.
8
Differentiation of true progression from treatment response in high-grade glioma treated with chemoradiation: a comparison study of 3D-APTW and 3D-PcASL imaging and DWI.同步放化疗治疗高级别胶质瘤中真正进展与治疗反应的鉴别:3D-APTW和3D-PcASL成像及DWI的比较研究
NMR Biomed. 2023 Jan;36(1):e4821. doi: 10.1002/nbm.4821. Epub 2022 Sep 17.
9
Differentiation between glioblastoma and solitary brain metastases using perfusion and amide proton transfer weighted MRI.使用灌注和酰胺质子转移加权磁共振成像鉴别胶质母细胞瘤与孤立性脑转移瘤
Front Neurosci. 2025 Feb 5;19:1533799. doi: 10.3389/fnins.2025.1533799. eCollection 2025.
10
Chemical Exchange Saturation Transfer MRI for Differentiating Radiation Necrosis From Tumor Progression in Brain Metastasis-Application in a Clinical Setting.用于鉴别脑转移瘤中放射性坏死与肿瘤进展的化学交换饱和转移磁共振成像——临床应用
J Magn Reson Imaging. 2023 Jun;57(6):1713-1725. doi: 10.1002/jmri.28440. Epub 2022 Oct 11.

本文引用的文献

1
3-Tesla amide proton transfer-weighted imaging (APT-WI): elevated signal also in tumor mimics.3 特斯拉酰胺质子转移加权成像(APT-WI):在肿瘤模拟物中也出现信号增强。
Eur Radiol. 2025 Jun;35(6):3558-3567. doi: 10.1007/s00330-024-11202-8. Epub 2024 Nov 26.
2
Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: An overview.既往放疗后复发性脑转移瘤的多学科管理策略:综述
Neuro Oncol. 2025 Mar 7;27(3):597-615. doi: 10.1093/neuonc/noae220.
3
Is pulsed saturation transfer sufficient for differentiating radiation necrosis from tumor progression in brain metastases?
脉冲饱和转移技术足以区分脑转移瘤中的放射性坏死与肿瘤进展吗?
Neurooncol Adv. 2024 Jul 29;6(1):vdae132. doi: 10.1093/noajnl/vdae132. eCollection 2024 Jan-Dec.
4
Performance of amide proton transfer imaging to differentiate true progression from therapy-related changes in gliomas and metastases.酰胺质子转移成像在鉴别胶质瘤和转移瘤的真性进展与治疗相关变化中的应用。
Eur Radiol. 2025 Feb;35(2):580-591. doi: 10.1007/s00330-024-11004-y. Epub 2024 Aug 12.
5
Fluid suppression in amide proton transfer-weighted (APTw) CEST imaging: New theoretical insights and clinical benefits.酰胺质子转移加权(APTw)化学交换饱和转移(CEST)成像中的流体抑制:新的理论见解和临床获益。
Magn Reson Med. 2024 Apr;91(4):1354-1367. doi: 10.1002/mrm.29915. Epub 2023 Dec 10.
6
APT weighted imaging in diffuse gliomas.弥漫性胶质瘤的APT加权成像。
BJR Open. 2023 Oct 3;5(1):20230025. doi: 10.1259/bjro.20230025. eCollection 2023.
7
Fast WASABI post-processing: Access to rapid B and B correction in clinical routine for CEST MRI.快速 WASABI 后处理:临床常规 CEST MRI 中快速 B 和 B 校正的应用。
Magn Reson Imaging. 2023 Oct;102:203-211. doi: 10.1016/j.mri.2023.06.001. Epub 2023 Jun 14.
8
Chemical Exchange Saturation Transfer MRI for Differentiating Radiation Necrosis From Tumor Progression in Brain Metastasis-Application in a Clinical Setting.用于鉴别脑转移瘤中放射性坏死与肿瘤进展的化学交换饱和转移磁共振成像——临床应用
J Magn Reson Imaging. 2023 Jun;57(6):1713-1725. doi: 10.1002/jmri.28440. Epub 2022 Oct 11.
9
DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment.DEGRO 中枢神经系统放射性坏死实践指南第 2 部分:治疗。
Strahlenther Onkol. 2022 Nov;198(11):971-980. doi: 10.1007/s00066-022-01973-8. Epub 2022 Aug 29.
10
Differentiation of true progression from treatment response in high-grade glioma treated with chemoradiation: a comparison study of 3D-APTW and 3D-PcASL imaging and DWI.同步放化疗治疗高级别胶质瘤中真正进展与治疗反应的鉴别:3D-APTW和3D-PcASL成像及DWI的比较研究
NMR Biomed. 2023 Jan;36(1):e4821. doi: 10.1002/nbm.4821. Epub 2022 Sep 17.